Aurora Cannabis Inc.
General ticker "ACB" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $226.3M (TTM average)
Aurora Cannabis Inc. does not follow the US Stock Market performance with the rate: -4.8%.
Estimated limits based on current volatility of 2.1%: low 4.07$, high 4.25$
Factors to consider:
- Total employees count: 2 (0.0%) as of 2025
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-03-31 to 2028-03-30
- 2026-03-31 to 2027-03-31 estimated range: [2.12$, 4.31$]
- 2027-03-31 to 2028-03-30 estimated range: [2.05$, 4.09$]
Financial Metrics affecting the ACB estimates:
- Positive: with PPE of -2.1 at the end of fiscal year the price was neutral
- Positive: -13.52 < Operating profit margin, % of -12.71
- Positive: -40.59 < Investing cash flow per share per price, % of -28.32
- Negative: negative Operating cash flow
- Positive: Inventory ratio change, % of -5.59 <= -3.92
- Positive: -51.61 < Industry operating profit margin (median), % of -17.91
- Positive: Interest expense per share per price, % of 0.71 <= 0.75
- Positive: Industry inventory ratio change (median), % of -0.97 <= -0.92
- Positive: -28.70 < Return on assets ratio (scaled to [-100,100]) of -8.86
Short-term ACB quotes
Long-term ACB plot with estimates
Financial data
| YTD | 2025-03-31 | 2026-03-31 |
|---|---|---|
| Operating Revenue | CA$343.29MM | CA$320.59MM |
| Operating Expenses | CA$338.35MM | CA$367.25MM |
| Operating Income | CA$4.95MM | CA$-46.66MM |
| Non-Operating Income | CA$15.43MM | CA$-9.86MM |
| Interest Expense | CA$8.42MM | CA$1.81MM |
| R&D Expense | CA$3.68MM | CA$4.02MM |
| Income(Loss) | CA$20.38MM | CA$-56.52MM |
| Taxes | CA$4.62MM | CA$2.10MM |
| Net Income(Loss)* | CA$1.59MM | CA$-121.76MM |
| Stockholders Equity | CA$563.91MM | CA$513.15MM |
| Inventory | CA$237.72MM | CA$175.53MM |
| Assets | CA$847.77MM | CA$602.64MM |
| Operating Cash Flow | CA$16.00MM | CA$-13.51MM |
| Capital expenditure | CA$18.86MM | CA$22.55MM |
| Investing Cash Flow | CA$-14.33MM | CA$-72.61MM |
| Financing Cash Flow | CA$-0.12MM | CA$9.76MM |
| Earnings Per Share** | CA$0.03 | CA$-2.15 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.